Small mol­e­cules, bi­o­log­ics and now gene ther­a­pies: Ger­many's Evotec adds an­oth­er feath­er to its R&D cap

Ger­man drug dis­cov­ery com­pa­ny Evotec — which has a thriv­ing rolodex of bio­phar­ma part­ners such as Bay­er, Boehringer In­gel­heim, No­var­tis, No­vo Nordisk, Pfiz­er, Sanofi, and Take­da …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER